Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

[Neumonía acquired in the community. Practical guide elaborated by a committee intersocieties].

Luna CM, Calmaggi A, Caberloto O, Gentile J, Valentini R, Ciruzzi J, Clara L, Rizzo O, Lasdica S, Blumenfeld M, Benchetrit G, Famiglietti A, Apezteguia C, Monteverde A; Grupo Argentino de Estudio de la NAC.

Medicina (B Aires). 2003;63(4):319-43. Spanish.

PMID:
14518147
2.

Community-acquired pneumonia in the elderly.

Fung HB, Monteagudo-Chu MO.

Am J Geriatr Pharmacother. 2010 Feb;8(1):47-62. doi: 10.1016/j.amjopharm.2010.01.003. Review.

PMID:
20226392
3.

The role of new therapies for severe community-acquired pneumonia.

Restrepo MI, Anzueto A.

Curr Opin Infect Dis. 2006 Dec;19(6):557-64. Review.

PMID:
17075331
4.
5.

Improving outcomes of elderly patients with community-acquired pneumonia.

Gutiérrez F, Masiá M.

Drugs Aging. 2008;25(7):585-610. Review.

PMID:
18582147
6.

[Community-acquired pneumonia in adults. Clinical practice guideline for Argentina. Study Group on Community Acquired Pneumonia].

Luna CM, Efron ED, Schiavi E, Gené RJ, Famiglietti A, Jolly EC, Niederman MS.

Medicina (B Aires). 1997;57(3):343-55. Review. Spanish.

PMID:
9640771
7.

Management of community-acquired pneumonia by trained family general practitioners.

Potena A, Simoni M, Cellini M, Cartabellotta A, Ballerin L, Piattella M, Putinati S.

Int J Tuberc Lung Dis. 2008 Jan;12(1):19-25.

PMID:
18173872
8.

Guidelines for community-acquired pneumonia: are they reflected in practice?

Flanders SA, Halm EA.

Treat Respir Med. 2004;3(2):67-77. Review.

PMID:
15182208
9.

Severe community-acquired pneumonia: current outcomes, epidemiology, etiology, and therapy.

Restrepo MI, Jorgensen JH, Mortensen EM, Anzueto A.

Curr Opin Infect Dis. 2001 Dec;14(6):703-9. Review.

PMID:
11964888
10.

Severe community-acquired pneumonia: an Australian perspective.

Wilson PA, Ferguson J.

Intern Med J. 2005 Dec;35(12):699-705.

PMID:
16313544
11.

Health care-associated pneumonia and community-acquired pneumonia: a single-center experience.

Micek ST, Kollef KE, Reichley RM, Roubinian N, Kollef MH.

Antimicrob Agents Chemother. 2007 Oct;51(10):3568-73. Epub 2007 Aug 6.

12.

Severe community-acquired pneumonia: what's in a name?

Oosterheert JJ, Bonten MJ, Hak E, Schneider MM, Hoepelman AI.

Curr Opin Infect Dis. 2003 Apr;16(2):153-9. Review.

PMID:
12734448
13.

Medical resource utilization among community-acquired pneumonia patients initially treated with levofloxacin 750 mg daily versus ceftriaxone 1000 mg plus azithromycin 500 mg daily: a US-based study.

Frei CR, Jaso TC, Mortensen EM, Restrepo MI, Raut MK, Oramasionwu CU, Ruiz AD, Makos BR, Ruiz JL, Attridge RT, Mody SH, Fisher A, Schein JR.

Curr Med Res Opin. 2009 Apr;25(4):859-68. doi: 10.1185/03007990902779749 .

PMID:
19231913
14.
15.

Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study.

Marrie TJ, Shariatzadeh MR.

Medicine (Baltimore). 2007 Mar;86(2):103-11.

16.

Antimicrobial therapy for community-acquired pneumonia in adults.

da Cunha CA, Sader HS, Nicodemo AC; Brazilian Society for Infectious Diseases Practice Guidelines Committee.

Braz J Infect Dis. 2002 Apr;6(2):82-7.

17.

Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival.

Bodí M, Rodríguez A, Solé-Violán J, Gilavert MC, Garnacho J, Blanquer J, Jimenez J, de la Torre MV, Sirvent JM, Almirall J, Doblas A, Badía JR, García F, Mendia A, Jordá R, Bobillo F, Vallés J, Broch MJ, Carrasco N, Herranz MA, Rello J; Community-Acquired Pneumonia Intensive Care Units (CAPUCI) Study Investigators.

Clin Infect Dis. 2005 Dec 15;41(12):1709-16. Epub 2005 Nov 9.

PMID:
16288392
18.

Severity scoring in community-acquired pneumonia caused by Streptococcus pneumoniae: a 5-year experience.

Ioachimescu OC, Ioachimescu AG, Iannini PB.

Int J Antimicrob Agents. 2004 Nov;24(5):485-90.

PMID:
15519482
19.

[Adherence with national guidelines in hospitalized patients with community-acquired pneumonia. Results of CAPO study in Argentina].

Christensen D, Luna CM, Martínez J, Rodriguez E, Marzoratti L, Gonzalez J, Videla AJ, De Vedia L, Corral J, Benchetrit G, Rodriguez M, Victorio C, Lopardo G, Peyrani P, Ramirez J.

Medicina (B Aires). 2007;67(6 Pt 2):709-13. Spanish.

PMID:
18422063
20.

Appropriate outpatient macrolide use in community-acquired pneumonia.

Gotfried MH.

J Am Acad Nurse Pract. 2004 Apr;16(4):146, 148, 150 passim. Review.

PMID:
15137473

Supplemental Content

Support Center